[Management of perianal fistulizing Crohn's disease: a conservative approach].
Dignass
A U
AU
Medizinische Klinik m. S. Hepatologie, Gastroenterologie, Endokrinologie und Stoffwechselerkrankungen, Charité - Universitätsmedizin Berlin - Campus Virchow. axel.dignass@charite.de
D000890:Anti-Infective Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000150:complications* / Q000628:therapy; D005242:Fecal Incontinence / Q000209:etiology; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D010348:Patient Care Team; D011183:Postoperative Complications / Q000209:etiology; D012003:Rectal Fistula / Q000209:etiology / Q000628:therapy*; D012307:Risk Factors
D000890:Anti-Infective Agents; D008795:Metronidazole; D002939:Ciprofloxacin